Health-care provision and policy for non-alcoholic fatty liver disease in sub-Saharan Africa.

Autor:	Spearman CW; Division of Hepatology, Department of Medicine, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa. Electronic address: wendy.spearman@uct.ac.za., Abdo A; National Centre for Gastrointestinal and Liver Disease, Ibn Sina Hospital, Khartoum, Sudan., Ambali A; African Union Development Agency-New Partnership for Africa's Development (AUDA-NEPAD), Midrand, South Africa., Awuku YA; Department of Medicine, School of Medicine, University of Health and Allied Sciences, Ho, Ghana., Kassianides C; Department of Medicine, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa., Lesi OA; Gastroenterology & Hepatology Unit, College of Medicine, University of Lagos, Lagos, Nigeria., Ndomondo-Sigonda M; African Union Development Agency-New Partnership for Africa's Development (AUDA-NEPAD), Midrand, South Africa., Onyekwere CA; Department of Medicine, Lagos State University College of Medicine, Lagos, Nigeria., Rwegasha J; Gastroenterology Training Centre, Department of Internal Medicine, Muhimbili National Hospital, Dar Es Salaam, Tanzania., Shewaye AB; Division of Gastroenterolgy and Hepatology, Department of Internal Medicine, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia., Sonderup MW; Division of Hepatology, Department of Medicine, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.
Jazyk:	angličtina
Zdroj:	The lancet. Gastroenterology & hepatology [Lancet Gastroenterol Hepatol] 2021 Dec; Vol. 6 (12), pp. 1047-1056. Date of Electronic Publication: 2021 Sep 09.
DOI:	10.1016/S2468-1253(21)00296-X
Abstrakt:	Sub-Saharan Africa, which has a population of more than 1 billion people, carries 24% of the global burden of disease and spends the least on health care of any region, relying heavily on international development assistance to deliver health care for HIV, tuberculosis, and malaria. The demographic and epidemiological transitions occurring in sub-Saharan Africa, with rising prevalences of obesity and diabetes, enhance the risk of non-alcoholic fatty liver disease (NAFLD), yet this remains an unrecognised complication of metabolic syndrome. There are no guidance documents on NAFLD from sub-Saharan Africa, and non-communicable disease (NCD) guidance documents do not include the associated burden of fatty liver disease. Combating the health and socioeconomic burden of NAFLD requires an integrated liver health approach, with task-shifting to primary health care. Using clear guidance documents to link education and management of HIV, viral hepatitis, NAFLD, and associated NCDs is also crucial to an integrated approach to infectious diseases and NCDs, which requires targeted funding from both governments and international development agencies. Competing Interests: Declaration of interests We declare no competing interests. (Copyright © 2021 Elsevier Ltd. All rights reserved.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu